Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
130 participants
INTERVENTIONAL
2021-07-01
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active group
The active group get telemedicine devices, and lifestyle interventions.
telemedicine lifestyle guidance
Telemedicine lifestyle advices are given during 3 months, based on telemonitoring system data.
Comparator Group
The comparator group get the evidence based treatment.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
telemedicine lifestyle guidance
Telemedicine lifestyle advices are given during 3 months, based on telemonitoring system data.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of at least three of the following five risk factors (Metabolic Syndrome ATP III Criteria):
1. waist width above 102 cm in men and 88 cm in women
2. treated diabetes or blood sugar above 5.6 mmol / l
3. treated hypertension or spontaneous blood pressure ≥ 130/85 mmHg
4. fibrate treatment or triglyceride levels above 1.7 mmol / l
5. blood HDL cholesterol levels below 1.03 mmol / l in men and 1.3 mmol / l in women
Exclusion Criteria
* IT proficiency at least for basic use of mobile phones (answering / making voice calls).
* For women with childbearing potential, by definition, all women who are able to conceive physiologically use dual contraception
* Signing an informed consent.
* The subject communicates well with the investigator and is able to help understand and adhere to the requirements of the study plan.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Szeged University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Szeged
Szeged, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
István Kósa, MD, Ph.D.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TMED_METSZI_001
Identifier Type: -
Identifier Source: org_study_id